• Profile
Close

Benzodiazepines as a monotherapy in depressive disorders: A systematic review

Psychotherapy and Psychosomatics Evidence based | Feb 24, 2018

Benasi G, et al. - Researchers performed a systematic review and, when feasible, a meta-analysis of randomized controlled trials (RCT) which used benzodiazepines (BZD) as a monotherapy vs placebo, antidepressant drugs (AD), or both. Analysis of individual studies revealed that BZD were markedly more effective than placebo and as effective as tricyclic antidepressants (TCA) in more than half of the studies comparing BZD to TCA and/or placebo. Findings hereby indicate that in anxious depression, BZD are a therapeutic option and there are no indications that AD are preferable.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay